Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 16.49% vs -1.20% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -7.33% vs 25.00% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -0.93% vs 25.88% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs -18.18% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Nanjing Hicin Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 16.49% vs -1.20% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 25.97% vs -8.70% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -7.33% vs 25.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 21.93% vs 56.16% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -0.93% vs 25.88% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 16.06% vs 34.98% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs -18.18% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -28.00% vs 31.58% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






